Vasorelaxation induced by the new nitric oxide donor cis-[Ru(Cl)(bpy)2(NO)](PF6) is due to activation of KCa by a cGMP-dependent pathway

Claure N. Lunardi, Juliana A. Vercesi, Roberto S. da Silva, Lusiane M. Bendhack
  • Vascular Pharmacology, August 2007, Elsevier
  • DOI: 10.1016/j.vph.2007.05.003

The authors haven't finished explaining this publication. If you are the author, sign in to claim or explain your work.

Read Publication

http://dx.doi.org/10.1016/j.vph.2007.05.003

The following have contributed to this page: Claure N Lunardi